Bevacizumab plus neoadjuvant chemotherapy in patients with HER2-negative inflammatory breast cancer (BEVERLY-1): a multicentre, single-arm, phase 2 study

Authors

François Bertucci, Mahmoud Fekih, Aurélie Autret, Thierry Petit, Florence Dalenc, Christelle Levy, Gilles Romieu, Jacques Bonneterre, Jean-Marc Ferrero, Pierre Kerbrat, Patrick Soulie, Marie-Ange Mouret-Reynier, Thomas Bachelot, Florence Lerebours, Jean-Christophe Eymard, Mathilde Deblock, Alain Lortholary, Anne-Claire Hardy-Bessard, Philippe Barthelemy, Hervé Bonnefoi, Emmanuelle Charafe-Jauffret, François-Clément Bidard, Patrice Viens, Jérôme Lemonnier, Jean-Yves Pierga